Mind the Byte

Mind the Byte offers a pay-per-use SaaS platform with latest generation software

Startup

SOBRE MIND THE BYTE

      
Computational drug discovery can reduce development time and costs for new drugs by up to 30%, and in 2016 it is expected to represent 20% of total global RD&I expenditure in pharma companies.
 
Mind the Byte offers a pay-per-use SaaS platform (software as a service) with latest generation software (Cabrakan, Hurakan and Ixchel) that, starting from a molecule (SDF or SMILE file), allows users to predict which proteins it will interact with as well as its therapeutic indications in only minutes.

This platform was developed by Mind the Byte to break through the most important technological and economic barriers of computational design for companies and research centres
    

COMPARTIR PERFIL

PRINCIPIANTE
AVANZADO
PROFESIONAL

NOTICIAS

Noticias añadidas recientemente sobre Mind the Byte:
Equity Crowdfunding para una startup de bioinformática

Esta web usa cookies para que podamos entender cómo se utiliza el sitio. Si sigues navegando asumiremos que te parece bien. Si quieres utilizar este sitio sin cookies o si quieres saber más, puedes hacerlo aquí .